13D Filing: Kearny Venture Partners LP Files on Akebia Therapeutics, Inc. (AKBA)

Page 5 of 10

Page 5 of 10 SEC Filing

CUSIP NO. 00972D105 13D/A Page 5 of 10
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (Entities Only).

Kearny Venture Associates, L.L.C. (“KVA”)

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

(a)     ¨     (b)     x

3 SEC USE ONLY
4 SOURCE OF FUNDS WC
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) ¨
6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING
PERSON
WITH
7

SOLE VOTING POWER

1,560,309 shares, of which 1,529,120 are owned directly by KVP and 31,189 are owned directly by KVPE.
KVA, the general partner of KVP and KVPE, may be deemed to have sole power to vote these shares. Castelein, Spalding and Shapiro,
the managing members of KVA, may be deemed to have shared power to vote these shares.

8

SHARED VOTING POWER

See response to row 7.

9

SOLE DISPOSITIVE POWER

1,560,309 shares, of which 1,529,120 are owned directly by KVP and 31,189 are owned directly by KVPE.
KVA, the general partner of KVP and KVPE, may be deemed to have sole power to dispose of these shares. Castelein, Spalding and
Shapiro, the managing members of KVA, may be deemed to have shared power to dispose of these shares.

10

SHARED DISPOSITIVE POWER

See response to row 9.

11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,560,309
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) ¨
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 4.1%
14 TYPE OF REPORTING PERSON (See Instructions) OO

Follow Akebia Therapeutics Inc. (NASDAQ:AKBA)

Page 5 of 10